CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 185 enrolled
Drug / intervention
2 cranberry capsules +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01691430
NCT01691430Phase 3Completed
CompareCT.gov

A Randomized, Controlled Trial of Cranberry Capsules for UTI Prevention in Nursing Home Residents

Yale University·interventional·Posted Sep 24, 2012·Updated Mar 6, 2020

In Brief

A Phase 3 clinical trial evaluating 2 cranberry capsules and Placebo for Bacteriuria. Completed, enrolled 185 participants across 21 sites.

Detailed Summary

Urinary tract infection (UTI) is the most common infection in nursing home residents, and bacteriuria is the greatest trigger for antimicrobial therapy in the nursing home setting. The primary aim of this study is to test the efficacy of two oral cranberry capsules per day in the reduction of bacteriuria plus pyuria in female nursing home residents. These aims will be accomplished by conducting a double blind randomized placebo controlled efficacy trial of two oral cranberry capsules daily versus placebo in a cohort of Connecticut female nursing home residents.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBacteriuria
CountriesUnited States
CollaboratorsNational Institute on Aging (NIA)

Timeline

Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 24, 2012
Enrollment StartAug 1, 2012
Primary CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 13.8 years ago

Interventions

2 cranberry capsulesdietary

Two cranberry capsules qd (each capsule containing 36mg proanthocyanidin, total 72mg PAC)

Placebodietary

Two placebo capsules qd (each capsule containing 36mg proanthocyanidin, total 72mg PAC)